Jazz Pharmaceuticals plc (JAZZ)
USD 110.51
(-8.54%)
USD 110.51
(-8.54%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 11.39 Billion USD | 5.15% |
| 2022 | 10.83 Billion USD | -11.9% |
| 2021 | 12.29 Billion USD | 88.17% |
| 2020 | 6.53 Billion USD | 18.0% |
| 2019 | 5.53 Billion USD | 6.45% |
| 2018 | 5.2 Billion USD | 1.56% |
| 2017 | 5.12 Billion USD | 6.74% |
| 2016 | 4.8 Billion USD | 42.88% |
| 2015 | 3.35 Billion USD | 0.62% |
| 2014 | 3.33 Billion USD | 49.18% |
| 2013 | 2.23 Billion USD | 13.82% |
| 2012 | 1.96 Billion USD | 675.51% |
| 2011 | 253.57 Million USD | 86.82% |
| 2010 | 135.72 Million USD | 26.38% |
| 2009 | 107.39 Million USD | -8.6% |
| 2008 | 117.49 Million USD | -43.39% |
| 2007 | 207.55 Million USD | -3.27% |
| 2006 | 214.57 Million USD | 30.22% |
| 2005 | 164.78 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 11.36 Billion USD | 0.31% |
| 2024 Q1 | 11.32 Billion USD | -0.58% |
| 2023 Q4 | 11.39 Billion USD | 1.69% |
| 2023 Q2 | 11.26 Billion USD | 1.93% |
| 2023 Q1 | 11.04 Billion USD | 1.96% |
| 2023 Q3 | 11.2 Billion USD | -0.5% |
| 2023 FY | 11.39 Billion USD | 5.15% |
| 2022 Q4 | 10.83 Billion USD | 4.34% |
| 2022 Q2 | 11.2 Billion USD | -4.83% |
| 2022 FY | 10.83 Billion USD | -11.9% |
| 2022 Q1 | 11.76 Billion USD | -4.31% |
| 2022 Q3 | 10.38 Billion USD | -7.28% |
| 2021 Q3 | 12.47 Billion USD | -5.56% |
| 2021 Q2 | 13.21 Billion USD | 95.56% |
| 2021 FY | 12.29 Billion USD | 88.17% |
| 2021 Q1 | 6.75 Billion USD | 3.37% |
| 2021 Q4 | 12.29 Billion USD | -1.44% |
| 2020 Q2 | 6.06 Billion USD | 16.32% |
| 2020 Q1 | 5.21 Billion USD | -5.84% |
| 2020 Q4 | 6.53 Billion USD | 3.88% |
| 2020 Q3 | 6.29 Billion USD | 3.72% |
| 2020 FY | 6.53 Billion USD | 18.0% |
| 2019 Q3 | 5.52 Billion USD | 0.71% |
| 2019 Q4 | 5.53 Billion USD | 0.2% |
| 2019 FY | 5.53 Billion USD | 6.45% |
| 2019 Q1 | 5.28 Billion USD | 1.47% |
| 2019 Q2 | 5.48 Billion USD | 3.95% |
| 2018 Q4 | 5.2 Billion USD | -5.15% |
| 2018 Q2 | 5.34 Billion USD | 1.17% |
| 2018 Q1 | 5.28 Billion USD | 3.19% |
| 2018 FY | 5.2 Billion USD | 1.56% |
| 2018 Q3 | 5.48 Billion USD | 2.56% |
| 2017 Q3 | 4.99 Billion USD | 4.06% |
| 2017 Q2 | 4.8 Billion USD | -0.25% |
| 2017 FY | 5.12 Billion USD | 6.74% |
| 2017 Q1 | 4.81 Billion USD | 0.32% |
| 2017 Q4 | 5.12 Billion USD | 2.49% |
| 2016 Q1 | 3.53 Billion USD | 5.22% |
| 2016 FY | 4.8 Billion USD | 42.88% |
| 2016 Q4 | 4.8 Billion USD | -2.64% |
| 2016 Q3 | 4.93 Billion USD | 42.99% |
| 2016 Q2 | 3.44 Billion USD | -2.46% |
| 2015 Q1 | 3.23 Billion USD | -3.04% |
| 2015 FY | 3.35 Billion USD | 0.62% |
| 2015 Q2 | 3.39 Billion USD | 4.81% |
| 2015 Q3 | 3.46 Billion USD | 2.09% |
| 2015 Q4 | 3.35 Billion USD | -3.02% |
| 2014 FY | 3.33 Billion USD | 49.18% |
| 2014 Q4 | 3.33 Billion USD | -0.26% |
| 2014 Q3 | 3.34 Billion USD | 6.08% |
| 2014 Q2 | 3.15 Billion USD | -1.27% |
| 2014 Q1 | 3.19 Billion USD | 42.81% |
| 2013 Q3 | 2.18 Billion USD | 4.38% |
| 2013 FY | 2.23 Billion USD | 13.82% |
| 2013 Q4 | 2.23 Billion USD | 2.41% |
| 2013 Q2 | 2.09 Billion USD | 4.19% |
| 2013 Q1 | 2 Billion USD | 2.2% |
| 2012 FY | 1.96 Billion USD | 675.51% |
| 2012 Q4 | 1.96 Billion USD | 13.89% |
| 2012 Q1 | 895.36 Million USD | 253.1% |
| 2012 Q2 | 1.69 Billion USD | 89.64% |
| 2012 Q3 | 1.72 Billion USD | 1.69% |
| 2011 Q3 | 207.81 Million USD | 7.45% |
| 2011 FY | 253.57 Million USD | 86.82% |
| 2011 Q1 | 154.17 Million USD | 13.59% |
| 2011 Q2 | 193.4 Million USD | 25.45% |
| 2011 Q4 | 253.57 Million USD | 22.02% |
| 2010 Q3 | 108 Million USD | 11.04% |
| 2010 FY | 135.72 Million USD | 26.38% |
| 2010 Q2 | 97.26 Million USD | -8.85% |
| 2010 Q1 | 106.7 Million USD | -0.64% |
| 2010 Q4 | 135.72 Million USD | 25.68% |
| 2009 FY | 107.39 Million USD | -8.6% |
| 2009 Q4 | 107.39 Million USD | 5.11% |
| 2009 Q3 | 102.17 Million USD | -5.9% |
| 2009 Q2 | 108.57 Million USD | -1.24% |
| 2009 Q1 | 109.93 Million USD | -6.44% |
| 2008 Q3 | 179.79 Million USD | -3.64% |
| 2008 Q4 | 117.49 Million USD | -34.65% |
| 2008 Q2 | 186.59 Million USD | -21.93% |
| 2008 FY | 117.49 Million USD | -43.39% |
| 2008 Q1 | 239.01 Million USD | 15.16% |
| 2007 Q4 | 207.55 Million USD | -19.79% |
| 2007 Q1 | 197.91 Million USD | -7.76% |
| 2007 Q2 | 276.87 Million USD | 39.9% |
| 2007 Q3 | 258.76 Million USD | -6.54% |
| 2007 FY | 207.55 Million USD | -3.27% |
| 2006 FY | 214.57 Million USD | 30.22% |
| 2006 Q4 | 214.57 Million USD | 0.0% |
| 2005 Q4 | 164.78 Million USD | 0.0% |
| 2005 FY | 164.78 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AbCellera Biologics Inc. | 1.48 Billion USD | -665.634% |
| Alkermes plc | 2.13 Billion USD | -433.341% |
| Agenus Inc. | 313.91 Million USD | -3529.464% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | -197.486% |
| Aptorum Group Limited | 20.64 Million USD | -55100.139% |
| Ardelyx, Inc. | 297.57 Million USD | -3728.684% |
| Arrowhead Pharmaceuticals, Inc. | 765.55 Million USD | -1388.254% |
| Bicycle Therapeutics plc | 595.34 Million USD | -1813.744% |
| BioXcel Therapeutics, Inc. | 73.7 Million USD | -15358.684% |
| ChromaDex Corporation | 54.96 Million USD | -20628.766% |
| Chimerix, Inc. | 212.77 Million USD | -5254.676% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -40198.531% |
| Caribou Biosciences, Inc. | 440.96 Million USD | -2483.716% |
| CRISPR Therapeutics AG | 2.22 Billion USD | -411.011% |
| Precision BioSciences, Inc. | 159.78 Million USD | -7030.609% |
| Dyadic International, Inc. | 8.21 Million USD | -138518.224% |
| Eton Pharmaceuticals, Inc. | 31.74 Million USD | -35795.901% |
| Fortress Biotech, Inc. | 167.52 Million USD | -6700.95% |
| Lantern Pharma Inc. | 43.64 Million USD | -26003.05% |
| HOOKIPA Pharma Inc. | 161.33 Million USD | -6961.839% |
| Inhibikase Therapeutics, Inc. | 14.5 Million USD | -78438.886% |
| Incyte Corporation | 6.78 Billion USD | -67.991% |
| IO Biotech, Inc. | 150.71 Million USD | -7459.388% |
| Jaguar Health, Inc. | 50.76 Million USD | -22344.219% |
| Novavax, Inc. | 1.85 Billion USD | -514.084% |
| Janux Therapeutics, Inc. | 380.4 Million USD | -2895.045% |
| Opthea Limited | 188.79 Million USD | -5934.899% |
| Ligand Pharmaceuticals Incorporated | 833.06 Million USD | -1267.645% |
| ContextLogic Inc. | 423 Million USD | -2593.465% |
| MiMedx Group, Inc. | 239.04 Million USD | -4666.159% |
| Pyxis Oncology, Inc. | 173.72 Million USD | -6458.235% |
| TransCode Therapeutics, Inc. | 5.16 Million USD | -220287.195% |
| NextCure, Inc. | 129.41 Million USD | -8703.535% |
| Ocuphire Pharma, Inc. | 53.94 Million USD | -21019.15% |
| Oncternal Therapeutics, Inc. | 36.72 Million USD | -30920.063% |
| Outlook Therapeutics, Inc. | 32.3 Million USD | -35172.465% |
| Vaxcyte, Inc. | 1.4 Billion USD | -709.235% |
| PDS Biotechnology Corporation | 59.39 Million USD | -19083.943% |
| Madrigal Pharmaceuticals, Inc. | 640.54 Million USD | -1678.692% |
| Pharming Group N.V. | 462.85 Million USD | -2361.545% |
| Pieris Pharmaceuticals, Inc. | 38.68 Million USD | -29355.427% |
| Avidity Biosciences, Inc. | 628.55 Million USD | -1712.627% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -60106.905% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -60106.905% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -6791.7% |
| Sol-Gel Technologies Ltd. | 45.28 Million USD | -25058.123% |
| Acelyrin, Inc. | 742.69 Million USD | -1434.067% |
| Salarius Pharmaceuticals, Inc. | 6.58 Million USD | -172879.871% |
| SELLAS Life Sciences Group, Inc. | 6.4 Million USD | -177837.826% |
| Summit Therapeutics Inc. | 202.94 Million USD | -5513.903% |
| Sensei Biotherapeutics, Inc. | 74.37 Million USD | -15219.008% |
| Senti Biosciences, Inc. | 119.48 Million USD | -9435.468% |
| Stoke Therapeutics, Inc. | 228.34 Million USD | -4889.603% |
| Syros Pharmaceuticals, Inc. | 168.17 Million USD | -6674.745% |
| Alaunos Therapeutics, Inc. | 8.26 Million USD | -137784.049% |
| Telomir Pharmaceuticals, Inc. Common Stock | 4.77 Million USD | -238565.955% |
| Entrada Therapeutics, Inc. | 469.19 Million USD | -2328.294% |
| VistaGen Therapeutics, Inc. | 123.65 Million USD | -9113.977% |
| Wave Life Sciences Ltd. | 274.94 Million USD | -4043.808% |
| Sorrento Therapeutics, Inc. | 472.84 Million USD | -2309.559% |
| TRACON Pharmaceuticals, Inc. | 10.1 Million USD | -112649.718% |
| Barinthus Biotherapeutics plc | 214.5 Million USD | -5211.441% |
| Psyence Biomedical Ltd. | 1.13 Million USD | -1006239.127% |
| Phathom Pharmaceuticals, Inc. | 413.84 Million USD | -2653.07% |
| Immix Biopharma, Inc. | 19.92 Million USD | -57080.765% |
| Keros Therapeutics, Inc. | 370.02 Million USD | -2979.078% |
| MEI Pharma, Inc. | 41.37 Million USD | -27436.819% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -35058.177% |
| Xeris Biopharma Holdings, Inc. | 340.79 Million USD | -3243.141% |
| Rigel Pharmaceuticals, Inc. | 117.22 Million USD | -9619.223% |
| Fortress Biotech, Inc. | 167.52 Million USD | -6700.95% |
| Precigen, Inc. | 151.04 Million USD | -7443.123% |
| Clearside Biomedical, Inc. | 34.01 Million USD | -33392.148% |
| AlloVir, Inc. | 190.79 Million USD | -5871.487% |
| C4 Therapeutics, Inc. | 376.45 Million USD | -2926.518% |
| Fate Therapeutics, Inc. | 506.21 Million USD | -2150.687% |
| ImmuCell Corporation | 43.8 Million USD | -25907.424% |
| IDEAYA Biosciences, Inc. | 649.31 Million USD | -1654.671% |
| Onconetix, Inc. | 88.82 Million USD | -12727.261% |
| PureTech Health plc | 693.97 Million USD | -1541.758% |
| VYNE Therapeutics Inc. | 97.68 Million USD | -11563.366% |
| Elevation Oncology, Inc. | 89.09 Million USD | -12688.451% |
| Kintara Therapeutics, Inc. | 6.2 Million USD | -183604.595% |
| Seer, Inc. | 436.26 Million USD | -2511.544% |
| Verrica Pharmaceuticals Inc. | 81.59 Million USD | -13862.963% |
| Innoviva, Inc. | 1.24 Billion USD | -816.228% |
| Aadi Bioscience, Inc. | 132.42 Million USD | -8503.761% |
| ESSA Pharma Inc. | 149.12 Million USD | -7540.287% |
| GlycoMimetics, Inc. | 45.31 Million USD | -25041.759% |
| GT Biopharma, Inc. | 14.1 Million USD | -80652.42% |
| Inhibrx Biosciences, Inc. | 307.89 Million USD | -3600.428% |
| Akebia Therapeutics, Inc. | 241.7 Million USD | -4613.785% |
| Catalyst Pharmaceuticals, Inc. | 471.9 Million USD | -2314.323% |
| Longboard Pharmaceuticals, Inc. | 50.69 Million USD | -22373.438% |
| Orchestra BioMed Holdings, Inc. | 95.21 Million USD | -11866.306% |
| Alzamend Neuro, Inc. | 631.58 Thousand USD | -1803822.652% |
| Rocket Pharmaceuticals, Inc. | 566.34 Million USD | -1911.749% |
| Aptose Biosciences Inc. | 12.92 Million USD | -88066.533% |
| ZyVersa Therapeutics, Inc. | 22.11 Million USD | -51420.361% |
| Soligenix, Inc. | 9.79 Million USD | -116190.496% |
| Century Therapeutics, Inc. | 360.69 Million USD | -3058.759% |
| Kura Oncology, Inc. | 448.93 Million USD | -2437.864% |
| TScan Therapeutics, Inc. | 272.14 Million USD | -4086.442% |
| Intensity Therapeutics, Inc. | 17.29 Million USD | -65776.606% |
| Ocean Biomedical, Inc. | 110.91 Million USD | -10172.494% |
| CytomX Therapeutics, Inc. | 205.15 Million USD | -5453.645% |
| Autolus Therapeutics plc | 375.38 Million USD | -2935.145% |
| Mineralys Therapeutics, Inc. | 251.63 Million USD | -4427.714% |
| EyePoint Pharmaceuticals, Inc. | 355.18 Million USD | -3107.734% |
| Eterna Therapeutics Inc. | 49.13 Million USD | -23089.284% |
| Adaptive Biotechnologies Corporation | 661.13 Million USD | -1623.306% |
| GRI Bio, Inc. | 2.95 Million USD | -385331.631% |
| Xenetic Biosciences, Inc. | 10.6 Million USD | -107331.553% |
| Tenaya Therapeutics, Inc. | 170.51 Million USD | -6581.734% |
| IGM Biosciences, Inc. | 423.41 Million USD | -2590.851% |
| INmune Bio, Inc. | 57 Million USD | -19887.998% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -5020.473% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -13473.015% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -43524.539% |
| Entero Therapeutics, Inc. | 6.88 Million USD | -165424.281% |
| Milestone Pharmaceuticals Inc. | 75.22 Million USD | -15045.507% |
| X4 Pharmaceuticals, Inc. | 147.25 Million USD | -7637.005% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -6784.038% |
| Coherus BioSciences, Inc. | 629.6 Million USD | -1709.607% |
| Verastem, Inc. | 149.71 Million USD | -7509.879% |
| Abeona Therapeutics Inc. | 64 Million USD | -17701.567% |
| Pliant Therapeutics, Inc. | 512.15 Million USD | -2124.596% |
| Tonix Pharmaceuticals Holding Corp. | 154.45 Million USD | -7276.395% |
| Histogen Inc. | 19.07 Million USD | -59635.537% |
| Aprea Therapeutics, Inc. | 22.65 Million USD | -50201.419% |
| Surrozen, Inc. | 46.08 Million USD | -24625.171% |
| Organovo Holdings, Inc. | 6.34 Million USD | -179351.236% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -264331.744% |
| Ovid Therapeutics Inc. | 144.02 Million USD | -7810.584% |
| Panbela Therapeutics, Inc. | 11.8 Million USD | -96437.528% |
| CASI Pharmaceuticals, Inc. | 75.26 Million USD | -15037.056% |
| Cadrenal Therapeutics, Inc. Common Stock | 8.51 Million USD | -133636.643% |
| Centessa Pharmaceuticals plc | 362.96 Million USD | -3038.934% |
| Hepion Pharmaceuticals, Inc. | 18.09 Million USD | -62866.227% |
| Arcturus Therapeutics Holdings Inc. | 429.4 Million USD | -2553.308% |
| BioRestorative Therapies, Inc. | 12.61 Million USD | -90239.454% |
| Apollomics, Inc. | 55.38 Million USD | -20470.457% |
| Amarin Corporation plc | 831.68 Million USD | -1269.914% |
| Mesoblast Limited | 669.15 Million USD | -1602.654% |
| Turnstone Biologics Corp. | 112.81 Million USD | -9999.153% |
| Kymera Therapeutics, Inc. | 575.75 Million USD | -1878.842% |
| Synaptogenix, Inc. | 31.11 Million USD | -36518.503% |
| Tiziana Life Sciences Ltd | 12.18 Million USD | -93410.826% |
| Aurinia Pharmaceuticals Inc. | 548.06 Million USD | -1978.845% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -193919.969% |
| Monopar Therapeutics Inc. | 7.34 Million USD | -155013.851% |
| Exelixis, Inc. | 2.94 Billion USD | -287.219% |
| Better Therapeutics, Inc. | 22.94 Million USD | -49559.412% |
| Nurix Therapeutics, Inc. | 364.53 Million USD | -3025.416% |
| Apellis Pharmaceuticals, Inc. | 788.73 Million USD | -1344.52% |
| NLS Pharmaceutics AG | 1.84 Million USD | -616877.474% |
| Dermata Therapeutics, Inc. | 7.97 Million USD | -142698.366% |
| Aridis Pharmaceuticals, Inc. | 14.69 Million USD | -77432.215% |
| Gritstone bio, Inc. | 177.76 Million USD | -6309.081% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -11845.229% |
| TNF Pharmaceuticals, Inc. | 17.86 Million USD | -63684.497% |
| Avid Bioservices, Inc. | 336.55 Million USD | -3285.269% |
| Insmed Incorporated | 1.32 Billion USD | -756.749% |
| Virpax Pharmaceuticals, Inc. | 9.62 Million USD | -118231.437% |
| MediWound Ltd. | 66.45 Million USD | -17043.44% |
| OmniAb, Inc. | 401.98 Million USD | -2734.275% |
| Alector, Inc. | 621.82 Million USD | -1732.239% |
| Seres Therapeutics, Inc. | 358.6 Million USD | -3077.178% |
| Checkpoint Therapeutics, Inc. | 5.37 Million USD | -211751.227% |
| Viracta Therapeutics, Inc. | 56.69 Million USD | -19996.943% |
| Zai Lab Limited | 1.03 Billion USD | -999.432% |
| Revance Therapeutics, Inc. | 478.45 Million USD | -2281.286% |
| Aura Biosciences, Inc. | 255.07 Million USD | -4366.67% |
| Lyell Immunopharma, Inc. | 750.02 Million USD | -1419.056% |
| Immunic, Inc. | 54.29 Million USD | -20882.631% |
| Tarsus Pharmaceuticals, Inc. | 266.22 Million USD | -4179.614% |
| Veracyte, Inc. | 1.13 Billion USD | -901.331% |
| InMed Pharmaceuticals Inc. | 11.82 Million USD | -96267.835% |
| FibroGen, Inc. | 423.52 Million USD | -2590.101% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -324219.926% |
| Adial Pharmaceuticals, Inc. | 4.73 Million USD | -240438.508% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.42 Million USD | -209742.622% |
| Cyclacel Pharmaceuticals, Inc. | 8.8 Million USD | -129296.468% |
| Amylyx Pharmaceuticals, Inc. | 517.45 Million USD | -2101.811% |
| TG Therapeutics, Inc. | 329.58 Million USD | -3356.859% |
| Galecto, Inc. | 38.22 Million USD | -29704.481% |
| Calithera Biosciences, Inc. | 28.67 Million USD | -39631.34% |
| Fortrea Holdings Inc. | 4.35 Billion USD | -161.483% |
| KalVista Pharmaceuticals, Inc. | 235.4 Million USD | -4739.917% |
| Aptevo Therapeutics Inc. | 24.84 Million USD | -45763.292% |
| XBiotech Inc. | 227.24 Million USD | -4913.734% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -11845.229% |
| Lyra Therapeutics, Inc. | 142.6 Million USD | -7889.733% |
| Foghorn Therapeutics Inc. | 285.91 Million USD | -3884.862% |
| Y-mAbs Therapeutics, Inc. | 127.86 Million USD | -8810.181% |
| Theravance Biopharma, Inc. | 381.99 Million USD | -2882.563% |
| Ultragenyx Pharmaceutical Inc. | 1.49 Billion USD | -664.135% |
| Metagenomi, Inc. Common Stock | 364.84 Million USD | -3022.82% |
| Vaxxinity, Inc. | 44.35 Million USD | -25587.911% |
| BioCryst Pharmaceuticals, Inc. | 516.96 Million USD | -2103.915% |
| Gain Therapeutics, Inc. | 18.6 Million USD | -61123.904% |
| Cartesian Therapeutics, Inc. | 305.05 Million USD | -3634.915% |
| NexImmune, Inc. | 8.59 Million USD | -132474.198% |
| Creative Medical Technology Holdings, Inc. | 10.71 Million USD | -106229.043% |
| Marker Therapeutics, Inc. | 17.12 Million USD | -66421.276% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | 65.558% |
| Chemomab Therapeutics Ltd. | 22.15 Million USD | -51334.66% |
| Scopus BioPharma Inc. | 392.26 Thousand USD | -2904405.628% |
| RAPT Therapeutics, Inc. | 173.32 Million USD | -6473.256% |
| Ainos, Inc. | 31.84 Million USD | -35681.135% |
| Pluri Inc. | 39.52 Million USD | -28724.244% |
| Prothena Corporation plc | 696.38 Million USD | -1536.079% |
| Adaptimmune Therapeutics plc | 282.61 Million USD | -3931.392% |
| Celularity Inc. | 143.88 Million USD | -7818.158% |
| Rallybio Corporation | 115.62 Million USD | -9754.142% |
| Cue Biopharma, Inc. | 61.53 Million USD | -18416.754% |
| MeiraGTx Holdings plc | 458.16 Million USD | -2386.721% |
| Omeros Corporation | 378.26 Million USD | -2911.973% |
| Humacyte, Inc. | 128.22 Million USD | -8785.581% |
| Immunocore Holdings plc | 597 Million USD | -1808.432% |
| Cocrystal Pharma, Inc. | 31.25 Million USD | -36348.252% |
| Cidara Therapeutics, Inc. | 68.53 Million USD | -16525.36% |
| Blueprint Medicines Corporation | 1.04 Billion USD | -985.857% |
| CalciMedica, Inc. | 12.18 Million USD | -93403.151% |
| Cabaletta Bio, Inc. | 253.65 Million USD | -4391.764% |
| Marinus Pharmaceuticals, Inc. | 170.9 Million USD | -6566.37% |
| Scholar Rock Holding Corporation | 311.03 Million USD | -3563.047% |
| Sana Biotechnology, Inc. | 565.29 Million USD | -1915.457% |
| Pulmatrix, Inc. | 33.95 Million USD | -33451.325% |
| Elicio Therapeutics, Inc. | 27.14 Million USD | -41870.673% |
| Vigil Neuroscience, Inc. | 140.85 Million USD | -7988.542% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | -775.754% |
| Adlai Nortye Ltd. American Depositary Shares | 130.18 Million USD | -8651.397% |
| Cytokinetics, Incorporated | 824.31 Million USD | -1282.159% |
| Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | -53838.167% |
| Nutriband Inc. | 7.51 Million USD | -151464.794% |
| Protara Therapeutics, Inc. | 78.95 Million USD | -14330.376% |
| Vor Biopharma Inc. | 209.82 Million USD | -5329.856% |
| Roivant Sciences Ltd. | 7.22 Billion USD | -57.749% |
| Evogene Ltd. | 51.1 Million USD | -22195.765% |
| ProKidney Corp. | 420.55 Million USD | -2609.144% |
| Applied Therapeutics, Inc. | 54.83 Million USD | -20678.289% |
| Hoth Therapeutics, Inc. | 9.52 Million USD | -119574.646% |
| BridgeBio Pharma, Inc. | 546.38 Million USD | -1985.245% |
| CorMedix Inc. | 82.05 Million USD | -13784.188% |
| BioLineRx Ltd. | 63.92 Million USD | -17723.01% |
| Tango Therapeutics, Inc. | 402.56 Million USD | -2730.177% |
| Galectin Therapeutics Inc. | 28.2 Million USD | -40301.982% |
| Atai Life Sciences N.V. | 293.47 Million USD | -3782.185% |
| Renovaro Biosciences Inc. | 163.12 Million USD | -6884.244% |
| Aerovate Therapeutics, Inc. | 127.41 Million USD | -8841.719% |
| Zentalis Pharmaceuticals, Inc. | 562.02 Million USD | -1927.191% |
| Sagimet Biosciences Inc. | 96.71 Million USD | -11679.856% |
| MediciNova, Inc. | 66.26 Million USD | -17092.339% |
| Praxis Precision Medicines, Inc. | 87.94 Million USD | -12854.654% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -255221.091% |
| GeoVax Labs, Inc. | 9.28 Million USD | -122630.693% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -1836.869% |
| Biomea Fusion, Inc. | 199.92 Million USD | -5598.76% |
| PTC Therapeutics, Inc. | 1.9 Billion USD | -498.648% |
| Mereo BioPharma Group plc | 66.49 Million USD | -17033.128% |
| Cullinan Oncology, Inc. | 485.09 Million USD | -2248.681% |
| Syndax Pharmaceuticals, Inc. | 612.88 Million USD | -1758.987% |
| Absci Corporation | 234.48 Million USD | -4758.99% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -155653.37% |
| 4D Molecular Therapeutics, Inc. | 339.89 Million USD | -3252.063% |
| Dyne Therapeutics, Inc. | 165.08 Million USD | -6801.636% |
| Kiniksa Pharmaceuticals, Ltd. | 526.32 Million USD | -2064.713% |
| Ventyx Biosciences, Inc. | 277.69 Million USD | -4002.861% |
| Allakos Inc. | 243.61 Million USD | -4576.885% |
| Imunon, Inc. | 21.91 Million USD | -51881.582% |
| Fulcrum Therapeutics, Inc. | 257.69 Million USD | -4321.274% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -1733.153% |
| BioAtla, Inc. | 119.65 Million USD | -9421.602% |
| NLS Pharmaceutics AG | 1.84 Million USD | -616877.474% |
| Bio-Path Holdings, Inc. | 3.22 Million USD | -353731.025% |
| Allogene Therapeutics, Inc. | 642.83 Million USD | -1672.356% |
| Larimar Therapeutics, Inc. | 95.93 Million USD | -11776.123% |
| XOMA Corporation | 234.3 Million USD | -4762.702% |
| Kezar Life Sciences, Inc. | 221.23 Million USD | -5049.89% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -8953.558% |
| aTyr Pharma, Inc. | 122.06 Million USD | -9233.693% |
| Aligos Therapeutics, Inc. | 153.9 Million USD | -7302.948% |
| Akero Therapeutics, Inc. | 580.27 Million USD | -1863.455% |
| Viridian Therapeutics, Inc. | 490.42 Million USD | -2223.165% |
| Eliem Therapeutics, Inc. | 110.46 Million USD | -10213.626% |
| EyeGate Pharmaceuticals, Inc. | 15.15 Million USD | -75066.186% |
| Akari Therapeutics, Plc | 4.35 Million USD | -261515.591% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -66772.902% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | -557.333% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -369336.145% |
| UroGen Pharma Ltd. | 178.31 Million USD | -6289.6% |
| Sutro Biopharma, Inc. | 470.73 Million USD | -2320.329% |
| ZIVO Bioscience, Inc. | 555.71 Thousand USD | -2050116.208% |
| Orgenesis Inc. | 14.55 Million USD | -78194.111% |
| Entera Bio Ltd. | 11.76 Million USD | -96741.13% |
| GH Research PLC | 226.3 Million USD | -4934.626% |
| Lisata Therapeutics, Inc. | 54.69 Million USD | -20731.095% |
| Reneo Pharmaceuticals, Inc. | 107.43 Million USD | -10504.787% |
| Xencor, Inc. | 952.69 Million USD | -1095.912% |
| 60 Degrees Pharmaceuticals, Inc. | 7.78 Million USD | -146273.255% |
| Replimune Group, Inc. | 487.72 Million USD | -2236.035% |
| Coeptis Therapeutics Holdings, Inc. | 8.07 Million USD | -141062.599% |
| Vanda Pharmaceuticals Inc. | 648.44 Million USD | -1657.041% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -369336.145% |
| Portage Biotech Inc. | 7.77 Million USD | -146363.029% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -255221.091% |
| Olema Pharmaceuticals, Inc. | 276.94 Million USD | -4013.943% |
| OncoCyte Corporation | 74.89 Million USD | -15113.052% |
| Qualigen Therapeutics, Inc. | 2.03 Million USD | -560252.648% |
| Processa Pharmaceuticals, Inc. | 5.78 Million USD | -196790.65% |
| Purple Biotech Ltd. | 44.3 Million USD | -25617.482% |
| CollPlant Biotechnologies Ltd. | 34.12 Million USD | -33286.154% |
| scPharmaceuticals Inc. | 94.47 Million USD | -11959.144% |
| ProMIS Neurosciences, Inc. | 18.04 Million USD | -63038.739% |
| HilleVax, Inc. | 344.43 Million USD | -3207.85% |
| NeuroSense Therapeutics Ltd. | 3.17 Million USD | -358632.966% |
| Tharimmune, Inc. | 10.94 Million USD | -103983.226% |
| Genprex, Inc. | 10.67 Million USD | -106673.448% |
| Neumora Therapeutics, Inc. Common Stock | 496.19 Million USD | -2196.145% |
| Atossa Therapeutics, Inc. | 96.25 Million USD | -11737.01% |
| XTL Biopharmaceuticals Ltd. | 2.42 Million USD | -469535.573% |
| Virios Therapeutics, Inc. | 4.16 Million USD | -273421.075% |
| OKYO Pharma Limited | 1.54 Million USD | -739121.769% |
| Savara Inc. | 177.56 Million USD | -6316.48% |
| Curis, Inc. | 77.28 Million USD | -14642.578% |
| Daré Bioscience, Inc. | 21.28 Million USD | -53434.649% |
| Carmell Therapeutics Corporation | 63.94 Million USD | -17716.376% |
| Titan Pharmaceuticals, Inc. | 8.08 Million USD | -140802.288% |
| Achieve Life Sciences, Inc. | 19.37 Million USD | -58716.576% |
| BeiGene, Ltd. | 5.8 Billion USD | -96.259% |
| Kiromic BioPharma, Inc. | 12.16 Million USD | -93526.091% |
| Revolution Medicines, Inc. Warrant | 2.08 Billion USD | -445.505% |
| Protagonist Therapeutics, Inc. | 357.95 Million USD | -3082.938% |
| Erasca, Inc. | 395.29 Million USD | -2782.228% |
| bluebird bio, Inc. | 619.16 Million USD | -1740.129% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -263429.646% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | -66.531% |
| DBV Technologies S.A. | 182.98 Million USD | -6126.356% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -263429.646% |
| Moderna, Inc. | 18.42 Billion USD | 38.167% |
| Vincerx Pharma, Inc. | 18.21 Million USD | -62442.455% |
| Fresh Tracks Therapeutics, Inc. | 11.58 Million USD | -98237.295% |
| Molecular Templates, Inc. | 35.38 Million USD | -32100.093% |
| Acrivon Therapeutics, Inc. Common Stock | 138.26 Million USD | -8140.234% |
| Travere Therapeutics, Inc. | 788.91 Million USD | -1344.184% |
| Monte Rosa Therapeutics, Inc. | 303.75 Million USD | -3650.838% |
| Spruce Biosciences, Inc. | 103.94 Million USD | -10860.844% |
| Celldex Therapeutics, Inc. | 465.62 Million USD | -2346.885% |
| Cogent Biosciences, Inc. | 313.43 Million USD | -3534.976% |
| MacroGenics, Inc. | 306.82 Million USD | -3613.369% |
| RenovoRx, Inc. | 1.46 Million USD | -777073.192% |
| Adicet Bio, Inc. | 207.29 Million USD | -5396.205% |
| Prime Medicine, Inc. | 193.85 Million USD | -5777.38% |
| Aditxt, Inc. | 44.57 Million USD | -25458.068% |
| Adagene Inc. | 115.72 Million USD | -9744.875% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -255689.752% |
| Quantum-Si incorporated | 298.25 Million USD | -3720.07% |
| Maravai LifeSciences Holdings, Inc. | 1.48 Billion USD | -665.966% |
| Acurx Pharmaceuticals, Inc. | 7.7 Million USD | -147690.598% |
| Voyager Therapeutics, Inc. | 351.28 Million USD | -3143.375% |
| SciSparc Ltd. | 11.18 Million USD | -101790.172% |
| Vericel Corporation | 353.65 Million USD | -3121.584% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -93191.769% |
| Minerva Neurosciences, Inc. | 56.9 Million USD | -19923.263% |
| Generation Bio Co. | 374.75 Million USD | -2940.191% |
| Astria Therapeutics, Inc. | 254.66 Million USD | -4373.844% |
| Black Diamond Therapeutics, Inc. | 158.56 Million USD | -7085.202% |
| Arcutis Biotherapeutics, Inc. | 341.36 Million USD | -3237.589% |
| Invivyd, Inc. | 229.18 Million USD | -4871.337% |
| Relay Therapeutics, Inc. | 843.98 Million USD | -1249.956% |
| Quoin Pharmaceuticals, Ltd. | 12.16 Million USD | -93523.775% |
| Spero Therapeutics, Inc. | 182.39 Million USD | -6146.702% |
| Artelo Biosciences, Inc. | 20.42 Million USD | -55684.171% |
| 2seventy bio, Inc. | 565.42 Million USD | -1915.004% |
| ADMA Biologics, Inc. | 329.18 Million USD | -3361.112% |
| Clene Inc. | 52.34 Million USD | -21667.561% |
| Capricor Therapeutics, Inc. | 58.73 Million USD | -19298.126% |
| Boundless Bio, Inc. Common Stock | 129.89 Million USD | -8671.274% |
| GeoVax Labs, Inc. | 9.28 Million USD | -122630.693% |
| Recursion Pharmaceuticals, Inc. | 653.69 Million USD | -1642.906% |
| Citius Pharmaceuticals, Inc. | 103.61 Million USD | -10896.267% |
| Contineum Therapeutics, Inc. Class A Common Stock | 130.38 Million USD | -8638.177% |
| Relmada Therapeutics, Inc. | 97.55 Million USD | -11579.262% |
| Finch Therapeutics Group, Inc. | 70.99 Million USD | -15947.663% |
| ALX Oncology Holdings Inc. | 242.55 Million USD | -4597.266% |
| Vir Biotechnology, Inc. | 1.96 Billion USD | -481.267% |
| Evaxion Biotech A/S | 12.88 Million USD | -88298.602% |
| Ocular Therapeutix, Inc. | 252.06 Million USD | -4420.098% |
| Verve Therapeutics, Inc. | 752.68 Million USD | -1413.689% |
| Trevena, Inc. | 40.6 Million USD | -27959.005% |
| Surrozen, Inc. | 46.08 Million USD | -24625.171% |
| Tyra Biosciences, Inc. | 225.85 Million USD | -4944.501% |
| Cingulate Inc. | 3.49 Million USD | -326223.009% |
| Galmed Pharmaceuticals Ltd. | 16.62 Million USD | -68414.998% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -17244.13% |
| Tenax Therapeutics, Inc. | 11.68 Million USD | -97407.255% |
| Terns Pharmaceuticals, Inc. | 268.51 Million USD | -4143.068% |
| ACADIA Pharmaceuticals Inc. | 748.95 Million USD | -1421.232% |
| Connect Biopharma Holdings Limited | 125.89 Million USD | -8950.106% |
| Clearmind Medicine Inc. | 4.32 Million USD | -263367.486% |
| Kronos Bio, Inc. | 213.27 Million USD | -5241.998% |
| Bolt Biotherapeutics, Inc. | 159.78 Million USD | -7030.476% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -132990.504% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -2991.905% |
| Statera Biopharma, Inc. | 21.16 Million USD | -53719.218% |
| ImmunityBio, Inc. | 504.45 Million USD | -2158.562% |
| Korro Bio, Inc. | 221.66 Million USD | -5039.946% |
| Kineta, Inc. | 10.28 Million USD | -110719.56% |
| BioVie Inc. | 25.2 Million USD | -45096.775% |
| Codexis, Inc. | 136.56 Million USD | -8243.055% |
| Celularity Inc. | 143.88 Million USD | -7818.158% |
| Crinetics Pharmaceuticals, Inc. | 635.35 Million USD | -1693.233% |
| Celcuity Inc. | 191.21 Million USD | -5858.265% |
| Virax Biolabs Group Limited | 5.48 Million USD | -207657.538% |
| Cibus, Inc. | 544.41 Million USD | -1992.786% |
| Eledon Pharmaceuticals, Inc. | 125.89 Million USD | -8949.962% |
| eFFECTOR Therapeutics, Inc. | 20.54 Million USD | -55358.328% |
| IN8bio, Inc. | 33.7 Million USD | -33699.16% |
| Kodiak Sciences Inc. | 479.37 Million USD | -2276.726% |
| Annexon, Inc. | 297.67 Million USD | -3727.462% |
| Adverum Biotechnologies, Inc. | 173.01 Million USD | -6485.376% |
| Assembly Biosciences, Inc. | 137.46 Million USD | -8187.948% |
| Avalo Therapeutics, Inc. | 20.99 Million USD | -54172.181% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | -281.04% |
| Eyenovia, Inc. | 28.77 Million USD | -39488.627% |
| Puma Biotechnology, Inc. | 230.52 Million USD | -4842.289% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -157615.379% |
| Xilio Therapeutics, Inc. | 60.92 Million USD | -18600.323% |
| Arcellx, Inc. | 825.13 Million USD | -1280.792% |
| Cardiff Oncology, Inc. | 81.63 Million USD | -13856.122% |
| Enanta Pharmaceuticals, Inc. | 462.27 Million USD | -2364.628% |
| Regulus Therapeutics Inc. | 30.75 Million USD | -36951.574% |
| Moolec Science SA | 24.05 Million USD | -47271.095% |
| Acumen Pharmaceuticals, Inc. | 310.12 Million USD | -3573.796% |
| Geron Corporation | 394.07 Million USD | -2791.158% |
| LAVA Therapeutics N.V. | 101.71 Million USD | -11101.808% |
| Royalty Pharma plc | 16.38 Billion USD | 30.451% |
| Atea Pharmaceuticals, Inc. | 594.96 Million USD | -1814.953% |
| Greenwich LifeSciences, Inc. | 6.99 Million USD | -162782.921% |
| TFF Pharmaceuticals, Inc. | 12.02 Million USD | -94629.023% |
| Mersana Therapeutics, Inc. | 226.06 Million USD | -4939.971% |
| Humacyte, Inc. | 128.22 Million USD | -8785.581% |
| Structure Therapeutics Inc. | 482.01 Million USD | -2263.684% |
| 89bio, Inc. | 596.26 Million USD | -1810.775% |
| PMV Pharmaceuticals, Inc. | 252.15 Million USD | -4418.449% |
| Avenue Therapeutics, Inc. | 1.85 Million USD | -615757.243% |
| Genelux Corporation | 27.89 Million USD | -40746.66% |
| Trevi Therapeutics, Inc. | 89.4 Million USD | -12643.822% |
| Lexicon Pharmaceuticals, Inc. | 229.42 Million USD | -4865.963% |
| Notable Labs, Ltd. | 19.54 Million USD | -58204.892% |
| Liquidia Corporation | 120.43 Million USD | -9360.487% |
| Mustang Bio, Inc. | 17.74 Million USD | -64116.881% |
| Immunovant, Inc. | 666.71 Million USD | -1608.888% |
| Quantum-Si incorporated | 298.25 Million USD | -3720.07% |
| Arbutus Biopharma Corporation | 144.4 Million USD | -7790.083% |
| DiaMedica Therapeutics Inc. | 54.16 Million USD | -20936.483% |
| Vera Therapeutics, Inc. | 175.54 Million USD | -6390.241% |
| Acasti Pharma Inc. | 73.3 Million USD | -15443.464% |
| MiNK Therapeutics, Inc. | 4.55 Million USD | -250178.025% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -43524.539% |
| Xenon Pharmaceuticals Inc. | 964.79 Million USD | -1080.906% |
| Elevai Labs, Inc. Common Stock | 5.18 Million USD | -219428.69% |
| NeuroBo Pharmaceuticals, Inc. | 22.78 Million USD | -49912.55% |
| Tempest Therapeutics, Inc. | 51.6 Million USD | -21978.869% |
| Soleno Therapeutics, Inc. | 180.69 Million USD | -6205.438% |
| PepGen Inc. | 143.05 Million USD | -7864.488% |
| Moleculin Biotech, Inc. | 38.21 Million USD | -29712.28% |
| United Therapeutics Corporation | 7.16 Billion USD | -58.97% |
| Nuvectis Pharma, Inc. | 19.18 Million USD | -59286.807% |
| Solid Biosciences Inc. | 164.93 Million USD | -6807.62% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -193919.969% |
| Immuneering Corporation | 102.58 Million USD | -11006.312% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -264331.744% |
| Silo Pharma, Inc. | 7.74 Million USD | -146984.322% |
| Belite Bio, Inc | 94.64 Million USD | -11938.375% |
| XOMA Corporation | 234.3 Million USD | -4762.702% |
| ARS Pharmaceuticals, Inc. | 233.18 Million USD | -4785.911% |
| Bionomics Limited | 27.64 Million USD | -41106.99% |
| Apogee Therapeutics, Inc. | 401.4 Million USD | -2738.377% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -10509.527% |
| uniQure N.V. | 831.68 Million USD | -1269.906% |
| Cassava Sciences, Inc. | 151.66 Million USD | -7412.286% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -255689.752% |
| Poseida Therapeutics, Inc. | 273.88 Million USD | -4059.906% |
| Forte Biosciences, Inc. | 38.98 Million USD | -29128.73% |
| Anebulo Pharmaceuticals, Inc. | 4.07 Million USD | -279621.093% |
| Enlivex Therapeutics Ltd. | 36.83 Million USD | -30834.156% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -157615.379% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -324219.926% |
| FibroBiologics, Inc. Common Stock | 11.82 Million USD | -96282.362% |
| Altimmune, Inc. | 210.64 Million USD | -5308.925% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -1364.668% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -10509.527% |
| Compugen Ltd. | 121.33 Million USD | -9290.079% |
| Peak Bio, Inc. | 2.59 Million USD | -438711.168% |
| Zevra Therapeutics, Inc. | 172.32 Million USD | -6511.476% |
| Benitec Biopharma Inc. | 52.21 Million USD | -21722.178% |
| Spyre Therapeutics, Inc. | 341.85 Million USD | -3232.766% |
| NKGen Biotech, Inc. Common Stock | 34.77 Million USD | -32664.958% |
| Zura Bio Limited | 100.84 Million USD | -11198.116% |
| PolyPid Ltd. | 15.37 Million USD | -74017.61% |
| Aileron Therapeutics, Inc. | 119.28 Million USD | -9451.296% |
| NKGen Biotech, Inc. Warrants | 34.77 Million USD | -32664.958% |
| Instil Bio, Inc. | 325.63 Million USD | -3398.867% |
| argenx SE | 4.54 Billion USD | -150.819% |
| Immunome, Inc. | 148.54 Million USD | -7570.23% |
| Compass Therapeutics, Inc. | 156.87 Million USD | -7162.699% |
| Verona Pharma plc | 308.12 Million USD | -3597.654% |
| enGene Holdings Inc. Warrants | 86.95 Million USD | -13001.989% |
| Shattuck Labs, Inc. | 159.56 Million USD | -7040.307% |
| CervoMed Inc. | 9.97 Million USD | -114147.531% |
| LENZ Therapeutics, Inc. | 188.45 Million USD | -5945.633% |
| Plus Therapeutics, Inc. | 11.38 Million USD | -99947.058% |
| Dianthus Therapeutics, Inc. | 179.4 Million USD | -6250.636% |
| Moolec Science SA | 24.05 Million USD | -47271.095% |
| Enveric Biosciences, Inc. | 6.11 Million USD | -186142.685% |
| Inovio Pharmaceuticals, Inc. | 172.94 Million USD | -6487.873% |
| AnaptysBio, Inc. | 452.38 Million USD | -2418.487% |
| Design Therapeutics, Inc. | 289.64 Million USD | -3833.587% |
| Leap Therapeutics, Inc. | 72.82 Million USD | -15544.846% |
| NeurAxis, Inc. | 509.49 Thousand USD | -2236093.076% |
| Seelos Therapeutics, Inc. | 5.41 Million USD | -210187.172% |
| Lumos Pharma, Inc. | 40.63 Million USD | -27936.22% |
| Achilles Therapeutics plc | 161.45 Million USD | -6956.634% |
| enGene Holdings Inc. Common Stock | 86.95 Million USD | -13001.989% |
| 180 Life Sciences Corp. | 5.25 Million USD | -216525.363% |
| Opiant Pharmaceuticals, Inc. | 70.42 Million USD | -16077.361% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -132990.504% |
| Nutriband Inc. | 7.51 Million USD | -151464.794% |
| ORIC Pharmaceuticals, Inc. | 254.68 Million USD | -4373.492% |
| CG Oncology, Inc. Common stock | 199.3 Million USD | -5616.659% |
| Fractyl Health, Inc. Common Stock | 76.21 Million USD | -14849.56% |
| Rani Therapeutics Holdings, Inc. | 57.91 Million USD | -19572.213% |
| MoonLake Immunotherapeutics | 526.54 Million USD | -2063.816% |
| Palisade Bio, Inc. | 14.05 Million USD | -80979.981% |
| Tourmaline Bio, Inc. | 210.29 Million USD | -5317.798% |
| Beam Therapeutics Inc. | 1.45 Billion USD | -680.52% |
| Neurogene Inc. | 222.57 Million USD | -5018.931% |
| Mirum Pharmaceuticals, Inc. | 646.62 Million USD | -1661.984% |
| AEON Biopharma, Inc. | 6.84 Million USD | -166347.904% |
| CARGO Therapeutics, Inc. Common Stock | 453.03 Million USD | -2414.89% |
| Sesen Bio, Inc. | 189.17 Million USD | -5922.688% |
| Enliven Therapeutics, Inc. | 271.86 Million USD | -4090.784% |
| Kiora Pharmaceuticals, Inc. | 13.71 Million USD | -82991.212% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -1360.03% |
| Taysha Gene Therapies, Inc. | 266.99 Million USD | -4167.272% |
| Athira Pharma, Inc. | 160.24 Million USD | -7009.962% |
| Vaccinex, Inc. | 3.63 Million USD | -313680.198% |
| HCW Biologics Inc. | 28.51 Million USD | -39857.547% |
| XOMA Corporation | 234.3 Million USD | -4762.702% |
| Nektar Therapeutics | 398.03 Million USD | -2762.416% |
| Arvinas, Inc. | 1.3 Billion USD | -773.322% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -66772.902% |
| Merus N.V. | 458.49 Million USD | -2384.953% |
| Omega Therapeutics, Inc. | 204.36 Million USD | -5474.978% |
| Quince Therapeutics, Inc. | 180.2 Million USD | -6222.478% |
| Rezolute, Inc. | 132.73 Million USD | -8483.409% |
| Clene Inc. | 52.34 Million USD | -21667.561% |
| Indaptus Therapeutics, Inc. | 14.92 Million USD | -76243.153% |
| BeyondSpring Inc. | 24.8 Million USD | -45826.149% |
| Synlogic, Inc. | 75.55 Million USD | -14980.555% |
| Allarity Therapeutics, Inc. | 11.86 Million USD | -95949.224% |
| Phio Pharmaceuticals Corp. | 9.36 Million USD | -121571.924% |
| Peak Bio, Inc. | 2.59 Million USD | -438711.168% |
| Werewolf Therapeutics, Inc. | 174.83 Million USD | -6416.71% |
| Krystal Biotech, Inc. | 818.35 Million USD | -1292.227% |
| Karyopharm Therapeutics Inc. | 240.43 Million USD | -4638.585% |
| SpringWorks Therapeutics, Inc. | 725.78 Million USD | -1469.792% |
| Lipella Pharmaceuticals Inc. | 3.57 Million USD | -318401.672% |
| MannKind Corporation | 475.19 Million USD | -2297.602% |
| Ikena Oncology, Inc. | 192.09 Million USD | -5831.199% |
| Cyclerion Therapeutics, Inc. | 13.37 Million USD | -85090.362% |
| Gyre Therapeutics, Inc. | 116.53 Million USD | -9676.434% |
| Gossamer Bio, Inc. | 311.91 Million USD | -3552.701% |
| CohBar, Inc. | 16.36 Million USD | -69517.444% |
| Cognition Therapeutics, Inc. | 35.16 Million USD | -32301.556% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -155653.37% |
| Legend Biotech Corporation | 1.84 Billion USD | -516.321% |
| Mural Oncology plc | 301.74 Million USD | -3675.824% |
| Biora Therapeutics, Inc. | 31.21 Million USD | -36399.628% |
| PaxMedica, Inc. Common Stock | 5.68 Million USD | -200473.005% |
| Disc Medicine, Inc. | 367.99 Million USD | -2996.055% |
| Champions Oncology, Inc. | 26.13 Million USD | -43499.261% |
| REGENXBIO Inc. | 573.97 Million USD | -1885.009% |
| Ensysce Biosciences, Inc. | 2.7 Million USD | -420616.447% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -7279.788% |
| Cellectar Biosciences, Inc. | 12.07 Million USD | -94250.408% |
| Edgewise Therapeutics, Inc. | 340.03 Million USD | -3250.643% |
| Vaxart, Inc. | 91.83 Million USD | -12307.012% |
| PharmaCyte Biotech, Inc. | 59.9 Million USD | -18919.4% |
| Aldeyra Therapeutics, Inc. | 148.32 Million USD | -7581.249% |
| Cellectis S.A. | 334.27 Million USD | -3308.43% |
| Longeveron Inc. | 12.17 Million USD | -93456.898% |
| Repare Therapeutics Inc. | 253.9 Million USD | -4387.323% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | -249.0% |
| Inozyme Pharma, Inc. | 200.84 Million USD | -5572.656% |
| Revolution Medicines, Inc. | 2.08 Billion USD | -445.505% |
| Nymox Pharmaceutical Corporation | 1.62 Million USD | -701029.785% |
| Third Harmonic Bio, Inc. | 277.71 Million USD | -4002.596% |
| ArriVent BioPharma, Inc. Common Stock | 163.09 Million USD | -6885.591% |
| AN2 Therapeutics, Inc. | 138.74 Million USD | -8111.785% |
| Anixa Biosciences, Inc. | 25.52 Million USD | -44541.325% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | 49.876% |
| Denali Therapeutics Inc. | 1.15 Billion USD | -887.364% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -93191.769% |
| Veru Inc. | 50.59 Million USD | -22418.333% |
| Corvus Pharmaceuticals, Inc. | 45.55 Million USD | -24911.216% |
| Cingulate Inc. | 3.49 Million USD | -326223.009% |
| Passage Bio, Inc. | 150.54 Million USD | -7468.075% |
| Context Therapeutics Inc. | 16.06 Million USD | -70830.38% |
| Exicure, Inc. | 11.58 Million USD | -98288.247% |
| Day One Biopharmaceuticals, Inc. | 376.04 Million USD | -2929.762% |
| Oramed Pharmaceuticals Inc. | 161.64 Million USD | -6948.514% |
| Scinai Immunotherapeutics Ltd. | 17.47 Million USD | -65109.243% |
| Rhythm Pharmaceuticals, Inc. | 332.74 Million USD | -3324.051% |
| Nuvalent, Inc. | 732.38 Million USD | -1455.654% |
| ABVC BioPharma, Inc. | 14.94 Million USD | -76139.954% |
| Carisma Therapeutics, Inc. | 89.55 Million USD | -12622.334% |
| Unicycive Therapeutics, Inc. | 14.19 Million USD | -80185.808% |
| OmniAb, Inc. | 401.98 Million USD | -2734.275% |
| Anew Medical, Inc. | 19.45 Million USD | -58459.758% |
| Fennec Pharmaceuticals Inc. | 26.72 Million USD | -42529.359% |
| Lipocine Inc. | 23 Million USD | -49434.035% |
| Lexeo Therapeutics, Inc. Common Stock | 139.8 Million USD | -8049.348% |
| Nautilus Biotechnology, Inc. | 305.56 Million USD | -3628.62% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -13473.015% |
| G1 Therapeutics, Inc. | 121.54 Million USD | -9274.164% |
| Bellerophon Therapeutics, Inc. | 7.93 Million USD | -143483.604% |
| Sage Therapeutics, Inc. | 882.27 Million USD | -1191.358% |
| Ocugen, Inc. | 64.54 Million USD | -17551.26% |
| Mind Medicine (MindMed) Inc. | 124.54 Million USD | -9048.28% |
| Q32 Bio Inc. | 306.11 Million USD | -3621.873% |
| Brainstorm Cell Therapeutics Inc. | 4.2 Million USD | -270654.729% |
| Alumis Inc. Common Stock | 89.61 Million USD | -12614.1% |
| Equillium, Inc. | 50.53 Million USD | -22447.712% |
| Kyverna Therapeutics, Inc. | 75.19 Million USD | -15051.751% |
| Coya Therapeutics, Inc. | 41.27 Million USD | -27504.522% |
| CNS Pharmaceuticals, Inc. | 1.7 Million USD | -669761.475% |
| Galera Therapeutics, Inc. | 26.14 Million USD | -43484.251% |
| Evelo Biosciences, Inc. | 64.44 Million USD | -17580.295% |
| Comera Life Sciences Holdings, Inc. | 3.72 Million USD | -305588.585% |
| Dominari Holdings Inc. | 57.55 Million USD | -19694.571% |
| Edesa Biotech, Inc. | 8.89 Million USD | -128052.969% |
| vTv Therapeutics Inc. | 11.01 Million USD | -103306.78% |
| Bio-Techne Corporation | 2.81 Billion USD | -304.998% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | -1115.787% |
| Harmony Biosciences Holdings, Inc. | 811.44 Million USD | -1304.078% |
| Prelude Therapeutics Incorporated | 277.66 Million USD | -4003.275% |
| Candel Therapeutics, Inc. | 41.7 Million USD | -27220.893% |
| iTeos Therapeutics, Inc. | 667.58 Million USD | -1606.645% |
| Nkarta, Inc. | 378.88 Million USD | -2907.076% |
| BioCardia, Inc. | 2.98 Million USD | -381331.503% |
| Iterum Therapeutics plc | 26.25 Million USD | -43288.396% |